{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:13:49Z","timestamp":1783566829603,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"German Crohn and Colitis Organization"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2019.12.024","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T23:16:01Z","timestamp":1577142961000},"page":"1810-1817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany"],"prefix":"10.1016","volume":"38","author":[{"given":"Luana","family":"Cagol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Seitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ehrenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Frivolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Krahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Lainka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Gerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Lenhartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Vermehren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Radke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Trenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Koletzko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Michael","family":"Debatin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Posovszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.12.024_b0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier","year":"2014","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.vaccine.2019.12.024_b0010","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/ibd.20941","article-title":"Immunizations in patients with inflammatory bowel disease","volume":"15","author":"Lu","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.vaccine.2019.12.024_b0015","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1572-0241.2006.00646.x","article-title":"Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses","volume":"101","author":"Melmed","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0020","series-title":"Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2010","author":"Reiter","year":"2012"},{"key":"10.1016\/j.vaccine.2019.12.024_b0025","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10096-013-1836-6","article-title":"New preventive strategy to eliminate measles, mumps and rubella from Europe based on the serological assessment of herd immunity levels in the population","volume":"32","author":"Plans","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis: Off Publ Eur Soc Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0030","doi-asserted-by":"crossref","first-page":"11273","DOI":"10.3748\/wjg.v21.i40.11273","article-title":"Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease","volume":"21","author":"Marin","year":"2015","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.vaccine.2019.12.024_b0035","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/rheumatology\/keq183","article-title":"Vaccinations in patients with immune-mediated inflammatory diseases","volume":"49","author":"Rahier","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.vaccine.2019.12.024_b0040","first-page":"603","article-title":"Immunization status in children with inflammatory bowel disease","volume":"173","author":"Longuet","year":"2014","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2019.12.024_b0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1155\/2013\/539524","article-title":"Immunization history of children with inflammatory bowel disease","volume":"27","author":"Soon","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0050","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3109\/00365521.2011.574734","article-title":"The immunization status of patients with IBD is alarmingly poor before the introduction of specific guidelines","volume":"46","author":"Wilckens","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0055","first-page":"105","article-title":"Vaccination coverage in immunosuppressed patients: results of a regional health services research study","volume":"108","author":"Teich","year":"2011","journal-title":"Deutsches Arzteblatt Int"},{"key":"10.1016\/j.vaccine.2019.12.024_b0060","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.3748\/wjg.v23.i33.6030","article-title":"Autoimmune hepatitis: standard treatment and systematic review of alternative treatments","volume":"23","author":"Terziroli Beretta-Piccoli","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0065","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.3748\/wjg.v23.i30.5469","article-title":"Treating children with inflammatory bowel disease: current and new perspectives","volume":"23","author":"Guariso","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/MCG.0000000000000696","article-title":"Biological therapy in pediatric inflammatory Bowel disease: a systematic review","volume":"51","author":"Corica","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0075","first-page":"335","article-title":"Mitteilung der St\u00e4ndigen Impfkommission beim Robert Koch-Institut (RKI). Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) beim Robert Koch-Institut \u2013 2018\/2019","author":"Robert-Koch-Institut","year":"2018","journal-title":"Epidemiologisches Bull"},{"key":"10.1016\/j.vaccine.2019.12.024_b0080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3748\/wjg.v20.i1.6","article-title":"Immunopathology of inflammatory bowel disease","volume":"20","author":"Wallace","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0085","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.3748\/wjg.v20.i12.3255","article-title":"Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease","volume":"20","author":"Xu","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0090","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis\u2013update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaut.2018.10.020","article-title":"Etiopathogenesis of autoimmune hepatitis","volume":"95","author":"Floreani","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2019.12.024_b0100","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1440-1746.2010.06407.x","article-title":"Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience","volume":"25","author":"Lawrance","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0105","first-page":"129","article-title":"Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2014","author":"Robert-Koch-Institut","year":"2016","journal-title":"Epidemiologisches Bull"},{"key":"10.1016\/j.vaccine.2019.12.024_b0110","first-page":"135","article-title":"Impfquote bei Schuleingangsuntersuchung in Deutschland 2010","author":"Robert-Koch-Institut","year":"2012","journal-title":"Epidemiologisches Bull"},{"key":"10.1016\/j.vaccine.2019.12.024_b0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-230X-11-87","article-title":"An Australian audit of vaccination status in children and adolescents with inflammatory bowel disease","volume":"11","author":"Crawford","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0120","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/ibd\/izy366","article-title":"Serologic status of routine childhood vaccines, Cytomegalovirus, and Epstein-Barr virus in children with inflammatory bowel disease","volume":"25","author":"deBruyn","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.vaccine.2019.12.024_b0125","unstructured":"Horstk\u00f6tter N, M\u00fcller U, Ommen O, Platte A, Reckendrees B, Stander V, et al. Einstellungen, Wissen und Verhalten von Erwachsenen und Eltern gegen\u00fcber Impfungen \u2013 Ergebnisse der Repr\u00e4sentativbefragung 2016 zum Infektionsschutz. BZgA-Forschungsbericht. Bundeszentrale f\u00fcr Gesundheitliche Aufkl\u00e4rung. 2017."},{"key":"10.1016\/j.vaccine.2019.12.024_b0130","first-page":"1809","article-title":"A quality improvement project significantly increased the vaccination rate for immunosuppressed patients with IBD","volume":"19","author":"Parker","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.vaccine.2019.12.024_b0135","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1002\/ibd.21667","article-title":"Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge","volume":"17","author":"Wasan","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.vaccine.2019.12.024_b0140","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MPG.0b013e3181bab351","article-title":"Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy","volume":"50","author":"Lu","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.vaccine.2019.12.024_b0145","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/acr.20045","article-title":"Yellow fever revaccination during infliximab therapy","volume":"62","author":"Scheinberg","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.vaccine.2019.12.024_b0150","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.vaccine.2017.01.048","volume":"35","author":"Croce","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.024_b0155","first-page":"1","article-title":"Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Centers_for_Disease_Control_and_Prevention","year":"2007","journal-title":"MMWR Morbidity Mortality Weekly Rep"},{"key":"10.1016\/j.vaccine.2019.12.024_b0160","first-page":"1","article-title":"Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Centers_for_Disease_Control_and_Prevention","year":"2013","journal-title":"MMWR Morbidity Mortality Weekly Rep"},{"key":"10.1016\/j.vaccine.2019.12.024_b0165","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.12.024_b0170","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ibd.23027","article-title":"Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD","volume":"19","author":"Naganuma","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.vaccine.2019.12.024_b0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10620-018-5321-z","article-title":"Immunosuppression does not affect antibody concentrations to Measles, Mumps, and Rubella in patients with inflammatory bowel disease","volume":"64","author":"Caldera","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.vaccine.2019.12.024_b0180","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1016\/j.vaccine.2017.09.031","article-title":"Vaccination strategies in pediatric inflammatory bowel disease","volume":"35","author":"Dipasquale","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.024_b0185","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2011.11.109","article-title":"Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review","volume":"30","author":"Agarwal","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.024_b0190","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2008.120","article-title":"Immune response to influenza vaccine in children with inflammatory bowel disease","volume":"104","author":"Lu","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0195","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cgh.2007.02.035","article-title":"Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease","volume":"5","author":"Mamula","year":"2007","journal-title":"Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.vaccine.2019.12.024_b0200","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ajg.2009.523","article-title":"Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease","volume":"105","author":"Melmed","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0205","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s10620-018-5043-2","article-title":"Lower sustained diphtheria and pertussis antibody concentrations in inflammatory bowel disease patients","volume":"63","author":"Caldera","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.vaccine.2019.12.024_b0210","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/00365521.2014.928902","article-title":"Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy","volume":"50","author":"Balint","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0215","doi-asserted-by":"crossref","first-page":"e42867","DOI":"10.1371\/journal.pone.0042867","article-title":"Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity","volume":"7","author":"Poethko-Muller","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.vaccine.2019.12.024_b0220","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.vaccine.2017.12.075","article-title":"Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine","volume":"36","author":"Seagle","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.024_b0225","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"New England J Med"},{"key":"10.1016\/j.vaccine.2019.12.024_b0230","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/315347","article-title":"Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression","volume":"181","author":"Asanuma","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.12.024_b0235","article-title":"Effectiveness over time of varicella vaccine","volume":"851\u20135","author":"Vazquez","year":"2004","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2019.12.024_b0240","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jpeds.2004.06.035","article-title":"Effectiveness over time of varicella vaccine","volume":"145","author":"Krysan","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2019.12.024_b0245","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1016\/j.vaccine.2007.07.010","article-title":"Metaanalysis of vaccine effectiveness in varicella outbreaks","volume":"25","author":"Bayer","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.024_b0250","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2019.12.024_b0255","first-page":"121","article-title":"Inflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry","volume":"112","author":"Buderus","year":"2015","journal-title":"Deutsches Arzteblatt Int"},{"key":"10.1016\/j.vaccine.2019.12.024_b0260","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/MEG.0000000000000280","article-title":"A 'cocoon immunization strategy' among patients with inflammatory bowel disease","volume":"27","author":"Waszczuk","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0265","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/MPG.0b013e31821e1917","article-title":"Varicella immunity in inflammatory bowel disease","volume":"53","author":"Ansari","year":"2011","journal-title":"J Pediatr Gstroenterol Nutr"},{"key":"10.1016\/j.vaccine.2019.12.024_b0270","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/ibd.22950","article-title":"Varicella zoster virus infection in inflammatory bowel disease","volume":"18","author":"Cullen","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.vaccine.2019.12.024_b0275","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/j.1572-0241.2004.41389_7.x","article-title":"Disseminated primary varicella after initiation of infliximab for Crohn's disease","volume":"99","author":"Leung","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.vaccine.2019.12.024_b0280","first-page":"351","article-title":"Overwhelming varicella pneumonia in a patient with Crohn's disease treated with 6-mercaptopurine","volume":"20","author":"Deutsch","year":"1995","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.vaccine.2019.12.024_b0285","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/INF.0b013e3181586665","article-title":"The burden of varicella complications before the introduction of routine varicella vaccination in Germany","volume":"27","author":"Liese","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.12.024_b0290","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/MEG.0b013e328353750c","article-title":"Autoimmune hepatitis in children: an overview of the disease focusing on current therapies","volume":"24","author":"Della Corte","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19316664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19316664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:41:23Z","timestamp":1759401683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19316664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X19316664"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}